Results 101 to 110 of about 1,505 (151)

Does randomization matter in rare disease clinical trials. [PDF]

open access: yesPLoS One
Wied S   +3 more
europepmc   +1 more source

Disease progression and economic burden of duchenne muscular dystrophy: A retrospective study using Swedish register data. [PDF]

open access: yesJ Neuromuscul Dis
Sejersen T   +5 more
europepmc   +1 more source

Turning premature stop codons into therapeutic opportunities. [PDF]

open access: yesMol Ther Nucleic Acids
Williamson J, Jacków-Malinowska J.
europepmc   +1 more source

Small molecule BLVRB redox inhibitor promotes megakaryocytopoiesis and stress thrombopoiesis in vivo. [PDF]

open access: yesNat Commun
Nesbitt NM   +11 more
europepmc   +1 more source

RiboScreen<sup>TM</sup> Technology Delivers Small-Molecule Ribodrugs to Convert Ribosomal Proteins into Molecular Valves for Tailored Protein Production Levels in Rare and Prevalent Disease <sup>†</sup>. [PDF]

open access: yesBiomedicines
Edobor G   +21 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy